USpolicy

News

The FDA has awarded its latest national priority voucher to Johnson & Johnson for a combination regimen based on Tecvayli for multiple myeloma.

News

After pushing for restrictions on vaccines for COVID-19 and hepatitis B, the Trump administration seems to be turning its attention to RSV shots.

News

FDA approves its first 'national priority' drug – a version of the widely used antibiotic Augmentin XR – in double-quick time.

News

The FDA could make it harder for developers of CAR-T therapies to bring them to market by requiring full randomised controlled trials.

News

The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with MASH to help measure disease activity.

News

The FDA is rolling out a pilot programme that could make it easier to bring digital health technologies for chronic diseases to market more quickly.